TSG101 and hepatocellular carcinoma: Formerly, TSG101 was considered to be an oncosuppressor [45]; however, thereafter, the content of this protein was found to be increased in various types of cancer, e.g., breast, ovarian, and hepatocellular carcinomas [46,47,48].